FDA Warns Boston Scientific Recalls Transcarotid Catheter Over Tip Separation Issue

According to the FDA, Boston Scientific recalls specific batches of its ENROUTE Transcarotid Neuroprotection System and ENROUTE Transcarotid Neuroprotection System Plus due to arterial sheath catheter tip separation or partial separation. As of July 9, the defect has caused 1 serious injury and no deaths. Separated tips may require endovascular intervention or surgery for removal.

The affected devices are specific production batches of both ENROUTE system variants used in transcarotid procedures.

Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments